1 study on Inos nf kb cox2 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
**GHRH antagonists such as MZ-5-156 may have therapeutic utility not only as antiproliferatives but as suppressors of iNOS-driven nitrosative and oxidative stress in lung cancer**, a dual mechanism that broadens their…